Search by job, company or skills
Work Schedule
Standard (Mon-Fri)Environmental Conditions
OfficeHOW YOU WILL MAKE AN IMPACT
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are advancing life sciences research, solving complex analytical challenges, improving efficiency in their laboratories, enhancing patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our distributed team of more than 100,000 colleagues offers an outstanding combination of innovative technologies, convenient purchasing, and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD or equivalent experience. For more information, please visit www.thermofisher.com.
Our Finance teams play a crucial role in supporting our commercial and functional teams. They collaborate closely to make informed decisions that drive our Mission and establish us as a reliable industry leader. With a global presence spanning Financial Planning & Analysis, Tax, Treasury, Audit, Investor Relations, and Accounting, our Finance functions offer diverse opportunities for career development and unique perspectives. Join us, a Fortune 500 company, and unlock unlimited potential for a fulfilling career in the world leader of serving science.
WHAT WILL YOU DO
WHAT DO WE LOOK FOR
Date Posted: 28/11/2024
Job ID: 101754493
Thermo Fisher Scientific Inc. is an American supplier of scientific instrumentation, reagents and consumables, and software services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including: Life Technologies Corporation (2013), Alfa Aesar (2015),Affymetrix (2016),FEI Company (2016), BD Advanced Bioprocessing (2018),and PPD (2021).
As of 2017, the company had a market capitalization of $21 billion and was a Fortune 500 company. Annual revenue in 2021 was US$39.21 billion.
In March 2020, Thermo Fisher Scientific received emergency use authorization from the FDA for a test for SARS-CoV-2 to help mitigate the COVID-19 pandemic.